Physician profile
Peter M Lotze
NPI 1639171903
$48,349.47
in general payments reported to CMS, 2019-2025
31 companies · $4,901 in 2025
The $4,901 reported for 2025 was more than what 91% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $4,965 · 2021: $5,068 · 2022: $18K · 2023: $1,236 · 2024: $1,433 · 2025: $4,901.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $3,486 · Gift: $84.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $3,486.46 |
| Gift | $84.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $40,501.97 | 2019-2025 | Solyx Sis System, Axonics, Upsylon |
| Intuitive Surgical, INC. | $4,150.00 | 2025 | |
| Caldera Medical, INC | $632.88 | 2019-2024 | Desara |
| Sumitomo Pharma America, INC. | $579.30 | 2023-2025 | Gemtesa |
| Axonics, INC. | $523.40 | 2020-2024 | Axonics, Bulkamid |
| Medtronic, INC. | $387.87 | 2021-2025 | Venaseal, Interstim |
| Astellas Pharma US INC | $261.11 | 2019-2023 | Myrbetriq |
| Pfizer INC. | $171.85 | 2019-2021 | |
| Coopersurgical, INC. | $145.45 | 2023-2024 | Advincula Delineator Uterine Manipulator, Wallach Cryosurgical Equipment |
| Medtronic USA, INC. | $134.52 | 2019 | |
| Novo Nordisk INC | $126.69 | 2020 | |
| Coloplast Corp | $121.36 | 2019-2025 | |
| Myovant Sciences INC. | $115.03 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $88.03 | 2020-2023 | |
| Bluewind Medical | $80.51 | 2024 | Revi |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $33.71 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $29.59 | 2024 | |
| Lupin INC. | $26.95 | 2020 | |
| Abbvie INC. | $24.98 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.22 | 2021 | |
| Valencia Technologies Corporation | $22.86 | 2025 | Ecoin Device Kit |
| Therapeuticsmd, INC. | $20.32 | 2019 | |
| 180 Medical, INC. | $20.22 | 2020 | |
| Ascend Therapeutics US, LLC | $19.60 | 2020 | |
| Escala Medical INC. | $19.37 | 2024 | |
| Heron Therapeutics, INC. | $18.61 | 2025 | Zynrelef |
| Mayne Pharma Commercial LLC | $18.57 | 2024 | |
| Merck Sharp & Dohme LLC | $13.04 | 2021 | |
| Ethicon US, LLC | $12.99 | 2021 | |
| Covidien LP | $12.98 | 2019 | |
| Renovia INC | $12.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Lotze listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.